Steroids are important biological regulators existing in hormones which are used to control metabolism of the body. There are widespread applications in the pharmaceutical industry. Drugs of steroid nature - anti-inflammatory and antiallergic corticosteroids, diuretics, anabolics, androgens, gestagens, contraceptives, antitumor medications, etc. - are now widely used in human and veterinary medicine. Nowadays, biotechnological modifications of steroids are preferred over chemical modifications as a green chemistry since they are more likely to be natural. In this work four different Fusarium species were screened for bioconversion of steroids into pharmaceutically important derivatives of steroids by reduction, dehydrogenation, side-chain degradation etc. on A and D-rings containing many active sites. Fusarium spp. used in this work, namely Fusarium roseum OUT 4019, Fusarium anguioides OUT 4017, Fusarium bulbigenum OUT 4115 and Fusarium solani OUT 4021 are filamentous fungi, which belong to the class of Deuteromyces. They can grow using simple carbohydrates and nitrogen sources. 4-androstene-3,17-dione conversion is used as a model system. Under same environmental conditions it is found that whole cells of Fusarium roseum OUT 4019 can dehydrogenate at C-1 and C-2 producing androsta-1,4-diene-3,17-dione and also reduce at C-17 in addition to dehydrogenate at C-1 and C-2 producing 17-hydroxyandrosta- 1,4-dien-3-one, Fusarium anguioides OUT 4017 can reduce at C-17 producing 17-hydroxy-androst-4-en-3-one, Fusarium solani OUT 4021 can reduce at C-3 and C-17 producing androst-4-ene-3,17-diol at 25 C&deg / and 160 rpm with uncontrolled pH. In these conversions, androsta-1,4-diene-3,17-dione, 17-hydroxy-androsta-1,4-dien- 3-one, 17-hydroxy-androst-4-en-3-one, androst-4-ene-3,17-diol were isolated with 54 %, 22 %, 26 %, 90 % yields, respectively. In another study, bioconversion reactions of aromatic methyl ethers by Fusarium roseum OUT 4019 were investigated and for some compounds, cleavage of methyl ether was observed.

Cette thèse se divise en trois parties. La première concerne le développement d'une nouvelle voie d'accès à des hétérocycles azotés. Cette synthèse est basée sur deux étapes: l'addition radicalaire d'un xanthate, portant une fonction 1,2-dione, sur diverses oléfines suivie de sa condensation sur une diamine. Cette étude a permis de préparer des composés présentant un intérêt biologique certain tels que des pyrazines. De plus, une nouvelle méthodologie permettant l'accès à des structures imidazoles a été mise en évidence. La seconde partie a été consacrée à la préparation d'un support soluble à l'aide du procédé Madix. La dernière étude porte sur le développement de nouveaux agents modérateurs de la polymérisation radicalaire. Cette étude nous a amenés tout d'abord à synthétiser une large gamme de composés originaux de type dihydro-pyrazolone. Par la suite, la mise en place d'une étude modèle nous a permis de mesurer l'aptitude à se dissocier de ces composés puis de sélectionner les meilleurs candidats. Enfin, une étude poussée en polymérisation des agents sélectionnés a permis de mieux comprendre leur mécanisme d'action. Nous sommes en présence d'un système de type initer original. Ce système de polymérisation n'est cependant pas vivant du fait de l'irréversibilité de l'addition du contre radical dihydro-pyrazolone sur la chaîne polymère.

Les inhibiteurs mixtes de l'ECE et de l'ECA constituent une classe thérapeutique originale qui intervient dans la régulation de l'hémodynamique, en bloquant en amont la production de puissants vasoconstricteurs tels que l'angiotensine II et l'endothéline-1. Ces deux peptides sont générés, respectivement, grâce à l'enzyme de conversion de l'angiotensine II et de l'endothéline-1. En inhibant leur action, les agents thérapeutiques mixtes récents (1970) prennent ainsi une part importante dans le traitement de l'hypertension. Le premier type d'inhibiteurs porte un groupement phosphoré qui se lie au zinc présent dans le site actif de l'enzyme. Ces composés peptidiques, qui possèdent une certaine stéréochimie, ont été synthétisés via des réactions de substitution, de couplage peptidique et d'hydrogénolyse. Les premiers résultats pharmacologiques montrent que seule une activité vis à vis de l'enzyme de conversion de l'angiotensine est décelée. La seconde partie de ce travail présente la synthèse de dérivés cycliques, constitués de cinq ou six chaînons, et qui assurent une chélation au zinc grâce aux groupements carbonyles. Ces molécules sont obtenues en fonctionnalisant l'acide barbiturique ainsi que l'hydantoïne. Grâce à des réactions d'acylation et d'alkylation notamment, un premier composé final a pu être généré mais son inhibition, testée sur l'ECA, est encore faible et nécessite des modulations pour converger vers une activité mixte.

Submitted by Maike Costa (maiksebas@gmail.com) on 2017-06-27T14:51:56Z No. of bitstreams: 1 arquivototal.pdf: 8326748 bytes, checksum: beabc8048bb16f0e1b36cca198214348 (MD5) / Made available in DSpace on 2017-06-27T14:51:56Z (GMT). No. of bitstreams: 1 arquivototal.pdf: 8326748 bytes, checksum: beabc8048bb16f0e1b36cca198214348 (MD5) Previous issue date: 2015-04-06 / Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - CAPES / The breakthrough occurred in the scientific world involving chemical and pharmacological studies of heterocyclic are the result of the large investment from pharmaceutical companies and research centers in universities. Synthetic Heterocyclic compounds stand out because of the possibilities these compounds present several different biological properties. Structural changes in imidazolidínico and tioimidazolidínico rings can change their chemical, physical properties and produce biological effects with a variety of useful applications. The objective of this work was the synthesis and characterization of heterocyclic compounds of imidazolidine-2,4-dione class and 2-thioxo-imidazolidine-4-one in order to investigate their pharmacological potential as antimicrobial, antinociceptive, anti-tumor and anticonvulsant and study their thermal stability. The compounds were obtained in two steps: first, reacted sodium cyanide, ammonium chloride, methylammonium chloride, isopropylammonium chloride and substituted aromatic aldehydes to, followed by acid hydrolysis to form the amino acid derivatives of glycine. In the second stage, there was the reaction of amino acids prepared with potassium isocyanate and ammonium isothiocyanate and / or phenyl isocyanate and / or phenyl isothiocyanate followed by acid hydrolysis to form the imidazolidínicos derivatives: IM-15; HPA-05; HPA-09; HPA-10; HPA-14; HPA-15A; HPA-15B; HPA-15C; HPA-15D; HPA-15E; HPA-15F; HPA-15G; HPA-15H; HPA-15J and tioimidazolidínicos: HPA-03; HPA-04; HPA-08; HPA-11; HPA-15I; HPA-15M. The structures of the synthesized compounds were characterized by IR absorption spectroscopy, 1H-NMR and 13C-NMR. With the synthesized compounds investigated the potential front Antimicrobial studies, antinociceptive, anticarcinogenic and CNS. Also evaluated the thermal stability of the synthesized compounds and in silico studies. / O grande avanço ocorrido no mundo científico envolvendo os estudos químicos e farmacológicos de heterocíclicos são frutos do grande investimento das indústrias farmacêuticas e dos centros de pesquisas nas universidades. Os compostos heterocíclicos sintéticos se destacam devido às possibilidades existentes nesses compostos de apresentar várias propriedades biológicas diferentes. Modificações estruturais nos anéis imidazolidínico e tioimidazolidínico podem alterar suas propriedades químicas, físicas e produzir efeitos biológicos com uma grande variedade de aplicações úteis. O objetivo desse trabalho foi a síntese e caracterização de compostos heterocíclicos da classe imidazolidina-2,4-diona e 2-tioxo-imidazolidina-4-ona com a finalidade de investigar suas potencialidades farmacológicas como antimicrobianos, antinociceptivos, antitumoral e anticonvulsivante e estudar sua estabilidade térmica. Os compostos foram obtidos em duas etapas: na primeira, fez-se reagir cianeto de sódio, cloreto de amônio, cloreto de metilamônio, cloreto de isopropilamônio e aldeídos aromáticos para substituídos, seguido de hidrólise ácida para a formação dos aminoácidos derivados da glicina. Na segunda etapa, fez-se a reação dos aminoácidos preparados com isocianato de potássio e isotiocianato de amônio e/ou fenilisocianato e/ou fenilisotiocianato seguido de hidrólise ácida formando os derivados imidazolidínicos: IM-15; HPA-05; HPA-09; HPA-10; HPA-14; HPA-15A; HPA-15B; HPA-15C; HPA-15D; HPA-15E; HPA-15F; HPA-15G; HPA-15H; HPA-15J e tioimidazolidínicos: HPA-03; HPA-04; HPA-08; HPA-11; HPA-15I; HPA-15M. As estruturas dos compostos sintetizados foram caracterizadas através da espectroscopia de absorção no IV, de RMN de 1H e RMN de 13C. Com os compostos sintetizados investigou a potencialidade frente aos estudos Antimicrobianos, Antinociceptivos, Anticarcinogênico e sobre o SNC. Avaliou também a estabilidade térmica dos compostos sintetizados e os estudos in silico.

Bivalent drug design is an efficient strategy for increasing potency and selectivity of many drugs. We devised a strategy to prepare agonist-benzodiazepine heterodimers that could simultaneously bind to agonist and BZD sites of the GABAAR. We synthesized a benzodiazepine-MPEG model compound that relied on physiological GABA to elicit flux. We established that a tether at the N1 position of the BZD would not prevent binding to the receptor. However, coupling of GABA amides with long chain PEG tethers studied by another group member resulted in complete loss of agonist activity. We therefore ceased research in this particular area. 1,4-Benzodiazepin-2,5-diones display a wide range of pharmacological activities. Compounds containing the tricyclic proline-derived subtype have received attention as potent anxiolytic agents and as starting materials for anthramycin-inspired anticancer agents. More recently enantiopure (S)-proline-derived 1,4-benzodiazepin-2,5-diones have been recognized as selective α5 GABAA receptor ligands. Despite the impressive diversity of 1,4-benzodiazepine-2,5-diones prepared to date, enantiopure examples possessing a quaternary stereogenic center have been largely unexplored. "Memory of chirality" (MOC) is an emerging strategy for asymmetric synthesis. This technique enables the memory of a sole chiral center in the substrate to be retained in a process that destroys that center. We have used this technique to prepare a library of quaternary proline-derived, thioproline-derived and hydroxyproline-derived 1,4-benzodiazepin-2,5-diones, in high ee. We have developed an efficient synthetic method for preparing oxaproline-derived 1,4-benzodiazepin-2,5-diones in high yields, and by applying the MOC strategy we have prepared quaternary derivatives in acceptable %ee. We envision oxaproline-derived 1,4-benzodiazepin-2,5-diones may exhibit similar or more potent pharmacological properties than proline-derived 1,4-benzodiazepin-2,5-diones. Using density functional theory (DFT) methods, we modeled the formation of an enantiopure, dynamically chiral enolate intermediate and the slow racemization of the enolate on the alkylation reaction time scale. / Ph. D.

No description available.

No description available.